6622 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Zhaoke Ophthalmology Ltd. operates as holding company, which engages in the provision of ophthalmic pharmaceuticals. It focuses on the research, development, and commercialization of therapies and ophthalmic drugs. The company was founded in January 2017 and is headquartered in Guangzhou, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6622 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company